Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | CDK2 | P24941 | 1/20 | 0.36 |
| ▸ | GSK3B | P49841 | 1/20 | 0.36 |
| ▸ | PDE2A | O00408 | 4/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.34 |
| ▸ | EGLN2 | Q96KS0 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4819367 | 0.88 | PDE2A (0.38) | KMT2ACDK2GSK3BPDE2AMAPK1 | |
| SCHEMBL7830854 | 0.87 | PDE2A (0.33) | KMT2ACDK2GSK3BPDE2AMAPK1 | |
| SCHEMBL974907 | 0.86 | MAPK1 (0.41) | KMT2ACDK2GSK3BPDE2AMAPK1 | |
| SCHEMBL7487750 | 0.85 | MAPK1 (0.37) | KMT2ACDK2GSK3BPDE2AMAPK1 | |
| SCHEMBL4816384 | 0.85 | CDK2 (0.35) | KMT2ACDK2GSK3BPDE2AMAPK1 | |
| SCHEMBL7958939 | 0.85 | CDK2 (0.38) | KMT2ACDK2GSK3BPDE2AMAPK1 | |
| SCHEMBL7490009 | 0.84 | KMT2A (0.38) | KMT2ACDK2GSK3BPDE2AMAPK1 | |
| SCHEMBL7496989 | 0.84 | KMT2A (0.38) | KMT2ACDK2GSK3BPDE2AMAPK1 | |
| SCHEMBL6187065 | 0.84 | SMN1; SMN2 (0.38) | PDE2AMAPK1EGLN2ALDH1A1HPGD | |
| SCHEMBL4817675 | 0.84 | LMNA (0.39) | KMT2ACDK2GSK3BPDE2AMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0975634-B1 | FUNGICIDAL TRIFLUOROPHENYL-TRIAZOLOPYRIMIDINES | BASF AG (DE) | 2001-07-04 | — | — | EP | claimed |
| US-8974806-B2 | Method for producing aqueous active substance compositions of active substances that are hardly soluble in water | BASF AKTIENGESELLSCHAFT (DE) | 2015-03-10 | — | — | US | disclosed |
| US-8728504-B2 | Process for solubilizing hydrophobic active ingredients in aqueous medium | BASF SE (DE) | 2014-05-20 | — | — | US | disclosed |
| EP-2676680-A1 | Use of hydrophobin polypeptides as penetration enhancers | BASF SE (DE) | 2013-12-25 | — | — | EP | disclosed |
| US-8497230-B2 | Solid crop protection agents containing polyalkoxylate, method for their production and use thereof | BASF AKTIENGESELLSCHAFT (DE) | 2013-07-30 | — | — | US | disclosed |
| US-20130123108-A1 | ACTIVE SUBSTANCE COMPOSITION COMPRISING AT LEAST ONE NITROGEN ATOM-CONTAINING, HYPERBRANCHED POLYMER | BASF SE (DE) | 2013-05-16 | — | — | US | disclosed |
| EP-1763300-B1 | USE OF ETHER GROUP-CONTAINING POLYMERS AS SOLUBILIZERS | BASF SE (DE) | 2013-05-15 | — | — | EP | disclosed |
| US-20110312497-A1 | USE OF HYDROPHOBIN AS A SPREADING AGENT | BASF SE (DE) | 2011-12-22 | — | — | US | disclosed |
| US-20110195844-A1 | PROCESS FOR SOLUBILIZING HYDROPHOBIC ACTIVE INGREDIENTS IN AQUEOUS MEDIUM | BASF SE (DE) | 2011-08-11 | — | — | US | disclosed |
| EP-2308460-A1 | Composition comprising active agents and at least one nitrogen-containing hyper-branched polymer | BASF SE (DE) | 2011-04-13 | — | — | EP | disclosed |
| WO-2007048851-A1 | SOLID CROP PROTECTION AGENTS CONTAINING POLYALKOXYLATE, METHOD FOR THEIR PRODUCTION AND USE THEREOF | BASF SE (DE) | 2007-05-03 | — | — | WO | disclosed |
| WO-2006125647-A1 | METHOD FOR DETERMINING RESIDUES IN PLASTICS | BASF AKTIENGESELLSCHAFT (DE) | 2006-11-30 | — | — | WO | disclosed |
| WO-2006125644-A1 | METHOD FOR DETERMINING PESTICIDE RESIDUES IN SOIL OR PLANT MATERIAL | BASF AKTIENGESELLSCHAFT (DE) | 2006-11-30 | — | — | WO | disclosed |
| WO-2006087227-A2 | ACTIVE SUBSTANCE COMPOSITION COMPRISING AT LEAST ONE NITROGEN ATOM-CONTAINING, HYPERBRANCHED POLYMER | BASF AKTIENGESELLSCHAFT (DE) | 2006-08-24 | — | — | WO | disclosed |
| WO-2006084680-A1 | POLYMER COMPOSITIONS AND THEIR USE IN THE PRODUCTION OF ACTIVE OR EFFECTIVE INGREDIENT COMPOSITIONS | BASF AKTIENGESELLSCHAFT (DE) | 2006-08-17 | — | — | WO | disclosed |
| US-6297251-B1 | Fungicidal trifluorophenyl-triazolopyrimidines | AMERICAN CYANAMID CO. | 2001-10-02 | — | — | US | disclosed |
| EP-0975634-B1 | FUNGICIDAL TRIFLUOROPHENYL-TRIAZOLOPYRIMIDINES | BASF AG (DE) | 2001-07-04 | — | — | EP | disclosed |
| US-6117876-A | Fungicidal trifluorophenyl-triazolopyrimidines | AMERICAN CYANAMID COMPANY (US) | 2000-09-12 | — | — | US | disclosed |
| EP-0975634-A1 | FUNGICIDAL TRIFLUOROPHENYL-TRIAZOLOPYRIMIDINES | AMERICAN CYANAMID COMPANY (US) | 2000-02-02 | — | — | EP | disclosed |
| WO-1998046607-A1 | FUNGICIDAL TRIFLUOROPHENYL-TRIAZOLOPYRIMIDINES | AMERICAN CYANAMID COMPANY (US) | 1998-10-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110312497-A1 | USE OF HYDROPHOBIN AS A SPREADING AGENT | PFN1, DSTN, CHN2 | KMT2A 4413/4885CDK2 4151/4885GSK3B 1374/4885 |
| US-20110195844-A1 | PROCESS FOR SOLUBILIZING HYDROPHOBIC ACTIVE INGREDIENTS IN AQUEOUS MEDIUM | IDUA, PHOSPHO1, HDHD5 | KMT2A 1567/4885CDK2 1324/4885GSK3B 4556/4885 |
| US-20130123108-A1 | ACTIVE SUBSTANCE COMPOSITION COMPRISING AT LEAST ONE NITROGEN ATOM-CONTAINING, HYPERBRANCHED POLYMER | NOS1, NOS3, NPSR1 | KMT2A 3704/4885CDK2 3706/4885GSK3B 2664/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.